Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo.

The aim of this study was to develop an efficient method for packaging and concentrating lentiviral vectors that consistently yields high-titer virus on a scale suitable for in vivo applications. Transient cotransfection of 293T packaging cells with DNA plasmids encoding lentiviral vector components was optimized using SuperFect, an activated dendrimer-based transfection reagent. The use of SuperFect allowed reproducible and efficient production of high-titer lentiviral vector at concentrations greater than 1 x 10(7) transducing units per ml (TU/ml) and required less than one-third of the total amount of DNA used in traditional calcium phosphate transfection methods. Viral titers were further increased using a novel concentration protocol that yielded an average final titer of 1.4 x 10(10) TU/ml. Lentiviruses produced using these methods exhibited efficient transduction of central nervous system and peripheral tissues in vivo. The method is reproducible and can be scaled up to facilitate the use of these vectors in animal studies.

[1]  I. Verma,et al.  Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  M. Ohkawa,et al.  Neonatally administered diethylstilbestrol retards the development of the blood-testis barrier in the rat. , 2001, Journal of andrology.

[3]  Y. Ron,et al.  An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. , 2001, Virology.

[4]  Fred H. Gage,et al.  Development of a Self-Inactivating Lentivirus Vector , 1998, Journal of Virology.

[5]  J. Biegel,et al.  Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[7]  M. Kumar,et al.  Systematic determination of the packaging limit of lentiviral vectors. , 2001, Human gene therapy.

[8]  T. Iwakuma,et al.  Self-inactivating lentiviral vectors with U3 and U5 modifications. , 1999, Virology.

[9]  T. Iwakuma,et al.  Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system , 1999, Gene Therapy.

[10]  S. Semple-Rowland,et al.  Analyses of the guanylate cyclase activating protein-1 gene promoter in the developing retina. , 2002, Investigative ophthalmology & visual science.

[11]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[12]  Philippe Colin,et al.  The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain , 2001, Nature Biotechnology.

[13]  D. Trono,et al.  A stable system for the high-titer production of multiply attenuated lentiviral vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[15]  A. Consiglio,et al.  A new-generation stable inducible packaging cell line for lentiviral vectors. , 2001, Human gene therapy.

[16]  M. Huentelman,et al.  Large-scale production of retroviral vectors for systemic gene delivery. , 2002, Methods in enzymology.

[17]  G. Ramı́rez,et al.  Spatial and Temporal Patterns of Neurogenesis in the Chick Retina. , 1991, The European journal of neuroscience.

[18]  C. Tabin,et al.  Production and design of more effective avian replication-incompetent retroviral vectors. , 1999, Developmental biology.

[19]  Lung-Ji Chang,et al.  RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy , 2002, Journal of Virology.

[20]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[21]  T. Iwakuma,et al.  Contributions of Viral Splice Sites andcis-Regulatory Elements to Lentivirus Vector Function , 1999, Journal of Virology.

[22]  D. Kristoffersen,et al.  Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media. , 1992, European journal of radiology.

[23]  C. Cepko,et al.  Replication-competent retroviral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo , 1993, Molecular and cellular biology.

[24]  R. Braun,et al.  Absence of germline infection in male mice following intraventricular injection of adenovirus. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.